Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2013

AmpliPhi BioSciences Corp. (APHB) Starts Presentation at Rodman & Renshaw Global Investment Conference

AmpliPhi BioSciences is a biotechnology company engaged in developing and commercializing novel bacteriophage-based therapeutics for human and animal applications. AmpliPhi’s product development programs target Gram-negative infections that are often resistant to existing antibiotic treatments. The company was created through the … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Merus Labs International, Inc. (MSLI) Starts Presentation at Rodman & Renshaw Global Investment Conference

Merus Labs International acquires and licenses branded prescription pharmaceutical products throughout the U.S., Canada, and Europe. The specialty pharmaceutical company has products to treat overactive bladder, chronic bronchitis, pneumonia, and more. Its solutions can meet the needs of big wholesalers … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Alderon Iron Ore Corp. (AXX) Starts Presentation at Rodman & Renshaw Global Investment Conference

Alderon Iron Ore is a leading Canadian iron ore development company with offices in Vancouver, Toronto, Montreal, St. John’s, and Labrador City. Alderon’s team consists of skilled professionals with significant iron ore expertise. The company’s Kami Project – 75% owned … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Polymet Mining Corp. (PLM) Starts Presentation at Rodman & Renshaw Global Investment Conference

Polymet Mining Corp. is engaged in the acquisition, exploration and development of natural resource properties in the United States. Most of its interests are located in Minnesota, where it is also headquartered. Its NorthMet Project, for which it holds a … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Stellar Biotechnologies, Inc. (SBOTF) Starts Presentation at Rodman & Renshaw Global Investment Conference

Stellar Biotechnologies specializes in the production of KLH (keyhole limpet hemocyanin), a powerful immune-stimulating protein used in a new class of drugs known as conjugate vaccines. KLH is used as an essential carrier protein in vaccines being developed for use … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Synthetic Biologics, Inc. (SYN) Starts Presentation at Rodman & Renshaw Global Investment Conference

Synthetic Biologics is a bio-technology company, concentrating on the development of biologics for the prevention and treatment of infectious diseases and serious illness. The company is currently in Phase II testing with the product Trimesta for the treatment of cognitive … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Lightbridge Corp. (LTBR) Starts Presentation at Rodman & Renshaw Global Investment Conference

Lightbridge is a nuclear fuel technology company with a presence both in the United States and abroad. The company designs and develops proprietary nuclear fuels, which can be used with existing plants and new build reactors. Lightbridge also provides consulting … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Vision-Sciences Inc. (VSCI) Reports Positive Results from Study of EndoSheath Technology by British Army Field Hospital

Vision-Sciences is a leading developer, manufacturer, and provider of unique flexible endoscopic products utilizing its proprietary, sterile, disposable EndoSheath technology. This technology providers users in the medical community with quick, efficient endoscope turnover, while simultaneously ensuring enhanced patient safety. The … Continue reading

Posted in Small Cap News | Leave a comment

Soligenix, Inc. (SNGX) Starts Presentation at Rodman & Renshaw Global Investment Conference

Soligenix is a biopharmaceutical company focused on developing vaccines and medications in two specific areas: (1) a biotherapeutics segment for the development of orphan drugs designed to treat inflammatory diseases such as pediatric Crohn’s disease, oral mucositis, and acute radiation … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Supernus Pharmaceuticals, Inc. (SUPN) Starts Presentation at Rodman & Renshaw Global Investment Conference

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for treatment of diseases of the central nervous system (CNS). The company markets one product for Epilepsy called Oxtellar XR (TM). Supernus also received approval for an … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment